Skip to main content
. 2020 Jan 10;10:1338. doi: 10.3389/fneur.2019.01338

Table 1.

Demographic, neurologic data and neuropsychological data of PD, PD-ICD and HC groups.

PD-ICD (n = 15) PD-nonICD (n = 22) Healthy controls (n = 36) Statistics value, p Effect size
Gender M/F 11/4 10/12 19/17
Age 59.27 (8.88) 69.18 (5.47) 66.14 (7.70) F(2, 70) = 8.214, p = 0.001
Education 6.7, 13.3, 46.7, 33.4 4.5, 13.6, 68.2, 13.6 0, 16.7, 55.6, 27.7 χ2(2) = 0.658, p = 0.658
Socioeconomic status 6.7, 33.3, 46.7, 6.7 13.6, 22.7, 54.5, 9.0 2.8, 19.4, 52.8, 22.2 χ2(2) = 3.902, p = 0.142
Neurologic data d
H a Y stage 2.53 (0.64) 2.48 (0.66) p = 0.799, t = 0.256 d = 0.085927
Age of onset 50.80 (9.64) 62.55 (6.25) p < 0.001, t = −4.160 d = 1.445757
Diseases duration 8.87 (4.17) 6.95 (4.63) p = 0.208, t = 1.282 d = 0.433676
L-dopa equivalent dose 1289.75 (543.97) 1025.46 (567.18) p = 0.166, t = 1.414 d = 0.475602
Neuropsychological data η2
MADRS 3.73 (5.68) 3.05 (3.84) 0.69 (1.83) F(2, 70) = 5.202, p = 0.008 η2 = 0.129
SAS score 36.73 (5.40) 35.73 (5.25) 28.50 (6.59) F(2, 70) = 14.980, p < 0.001 η2 = 0.300

Education (%), Primary, lower secondary, higher secondary, college.

Socioeconomic status (%), insufficient, unsatisfactory, satisfactory, very satisfactory.

MADRS, Montgomery Asberg Depression Rating Scale; SAS, Zung Self-reported Anxiety Scale; M, male; F, female.